STOCK TITAN

UTHR affiliate to sell 8,300 shares via option exercise (NASDAQ: UTHR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

United Therapeutics affiliate filed a Form 144 proposing the sale of 8,300 shares of Common Stock via a stock option exercise on 03/19/2026. The filing lists multiple prior dispositions by the same holder in the past three months, including several 8,300-share transactions and an 11,000-share sale on 12/24/2025.

Positive

  • None.

Negative

  • None.

Insights

Routine affiliate resale via option exercise, consistent with standard insider dispositions.

The filing documents a proposed sale of 8,300 shares by an affiliate through a stock option exercise on 03/19/2026

Timing and mechanics are typical for a Form 144 notice; cash proceeds treatment is stated as Cash. Subsequent reporting will show whether the sale occurred.

Multiple recent disposals by the same holder suggest ongoing liquidity activity, not a single large block.

The excerpt lists several past sales in the last three months—multiple entries of 8,300 shares and one 11,000-share transaction on 12/24/2025. These are sequential dispositions rather than a single transformative event.

Market impact depends on execution and scale relative to float; follow-up SEC filings will confirm completed transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the UTHR Form 144 disclose?

It discloses a proposed sale of 8,300 shares via a stock option exercise on 03/19/2026. The filing also lists multiple prior dispositions by the same holder in the past three months, including an 11,000-share sale on 12/24/2025.

Who is the reported holder in the UTHR Form 144?

The filing names transactions by Paul Mahon at a Maryland address and shows repeated past dispositions. The notice indicates the sale on 03/19/2026 is through a stock option exercise with proceeds shown as Cash.

Does the Form 144 say how the shares will be sold?

Yes; the excerpt states the sale method as a Stock Option Exercise and lists the proceeds treatment as Cash. Further execution details and whether the shares were sold on-market will appear in subsequent transaction filings if completed.

Are there recent sales by the same holder listed?

Yes; the filing lists several past dispositions in the last three months, including multiple 8,300-share entries and one 11,000-share sale dated 12/24/2025. These entries are presented as prior sales by the same holder.

Does the Form 144 confirm the sale is completed?

No; the Form 144 provides notice of a proposed sale of 8,300 shares on 03/19/2026 via option exercise. Completion and execution details are not confirmed in this notice and would appear in later SEC transaction reports.
United Therapeutics Corp.

NASDAQ:UTHR

View UTHR Stock Overview

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

23.24B
42.93M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING